𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy

✍ Scribed by Eric L. Logigian; Emma Ciafaloni; L. Christine Quinn; Nuran Dilek; Shree Pandya; Richard T. Moxley III; Charles A. Thornton

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
200 KB
Volume
35
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutics development in myotonic dys
Therapeutics development in myotonic dystrophy type 1
✍ Erin Pennock Foff; Mani S. Mahadevan πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

## Abstract Myotonic dystrophy (DM1), the most common adult muscular dystrophy, is a multisystem, autosomal dominant genetic disorder caused by an expanded CTG repeat that leads to nuclear retention of a mutant RNA and subsequent RNA toxicity. Significant insights into the molecular mechanisms of R

Perspectives on gene therapy in myotonic
Perspectives on gene therapy in myotonic dystrophy type 1
✍ Jonathan J. MagaΓ±a; Bulmaro Cisneros πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 447 KB

Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disorder caused by a CTG expansion mutation located in the 3 0 untranslated region of the DMPK (DM1 protein kinase) gene. According to current evidence, mutant DMPK mRNAs containing the trinucleotide expansion are retained in the